Federal health officials are investigating the possibility that Johnson & Johnson’s coronavirus vaccine might slightly raise the risk of a rare neurological complication known as Guillain-Barré syndrome, a spokesperson from the US Centers for Disease Control and Prevention said in a statement to CNN on Monday.